Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may both prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer.
Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may both prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer.
<iframe src="https://statesidedaily.com/embed/cluster/ec42a350ab59d642231b477b30a6d460a3a90c69" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="GLP-1s appear to protect against cancer. Researchers are trying to figure out how"></iframe>
Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may both prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer.
